Influenza

Based on AMMI Canada’s 2025–26 seasonal influenza guideline update, which statement about treating influenza with the new antiviral baloxavir (Xofluza) is FALSE?

Updated guidance stresses the importance of vaccination and answers three key questions about influenza and antiviral use for the 2025–26 season.

The Public Health Agency of Canada’s website says 24% of cases tested positive for influenza during the week ending Feb. 8—up from the already-high 21% the week before.

Delivery of RSV immunization by family doctors better than expected.

Canadian healthcare providers should mention cardiovascular disease prevention as a benefit when promoting the usefulness of flu vaccines to the public.

Discusses the potential role of multiplex respiratory testing for SARS-CoV-2, influenza virus and RSV, and emerging issues related to highly pathogenic avian influenza virus.

So far, flu severity appears low overall in Australia, but it is still early days

NACI recommends offering influenza vaccine annually to anyone six months of age or older who does not have a contraindication to the vaccine.